Follow The Filings

MGRX Mangoceuticals

Mangoceuticals earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.09 —
Rev — — —

Insider trades

Open-market buys and sales by MGRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MGRX insider trades
  • None no insider bought on the open market
  • $174K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Eugene M Johnston CFO
    Sale
    $3,884 3,333 shares at $1.17 2.7% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
  2. Eugene M Johnston CFO
    Sale
    $5,975 5,000 shares at $1.20 3.9% of stake
    Traded Dec 9, 2025 Filed Dec 11, 2025
  3. Eugene M Johnston CFO
    Sale
    $11K 10,000 shares at $1.13 7.2% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
  4. Alex P. Hamilton Director
    Sale
    $153K 125,000 shares at $1.22 97% of stake
    Traded Nov 19, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 3 stock grants and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B5
8-K 1.01,9.01
SCHEDULE 13D/A —
8-K 1.01,2.01,3.02,7.01,9.01
8-K 1.02,9.01
10-Q
8-K 8.01,9.01
8-K 1.01,5.02,5.03,7.01,9.01
8-K 1.01,3.02,9.01
10-Q
10-K
8-K 5.02,7.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 3.01
S-1/A
S-1
8-K 1.01,8.01,9.01
424B5
8-K 1.01,3.02,9.01
8-K 1.01,2.03,9.01
8-K 8.01,9.01
10-Q/A
10-Q
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.